GlassScriptPhysician profile
Mark A Majeski
NPI 1932164845
$1,471.03
in general payments reported to CMS, 2019-2025
18 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2021: $143 · 2022: $146 · 2023: $26.99 · 2024: $596 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $521.23 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Amgen INC. | $311.74 | 2024-2025 | Krystexxa |
| Abbott Laboratories | $218.09 | 2021-2022 | |
| Nevro Corp. | $70.96 | 2022 | |
| Depuy Synthes Sales INC. | $55.55 | 2024 | Na, Va-Lcp, Vivigen Mis Delivery System |
| Paratek Pharmaceuticals, INC. | $51.62 | 2025 | Nuzyra |
| Medtronic Vascular, INC. | $48.17 | 2019 | |
| Ani Pharmaceuticals, INC. | $35.14 | 2025 | Purified Cortrophin Gel |
| Koya Medical, INC. | $28.30 | 2025 | Koya Medical, Dayspring |
| Smith+Nephew, INC. | $18.06 | 2019 | |
| Orthofix Medical, INC. | $16.21 | 2024 | Physio-Stim |
| Abbvie INC. | $15.00 | 2019 | |
| Integra Lifesciences Corporation | $14.90 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pfizer INC. | $14.70 | 2019 | |
| Organogenesis INC. | $13.68 | 2023 | Puraply |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.31 | 2023 | Krystexxa |
| Advanced Oxygen Therapy INC. | $12.20 | 2025 | Topical Oxygen Chamber For Extremities |
| Hikma Pharmaceuticals USA | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Majeski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.